TABLE 4.
Summary of the major peptide-based vaccines at early stage research for breast cancer therapy.
| Peptides | Sequence/Ref. |
|---|---|
| 249 | GDLTNRCTMEEKPMEK Mahdavi et al. (2017) |
| 1,412 | QPEQQETKKEEQ Mahdavi and Moreau (2016) |
| E39/E39′ | EIWTHSYKV/EIWTFSTKV Vreeland et al. (2018) |
| ErbB-2266-296/OVA323-339 | CGPSLLHCPALVTYNTDTFESMHNPEGRYTFGASCV/ISQAVHAAHAEINEAGR Wallis et al. (2020) |
| 45A2L/QA2L/PPE15L/PGRS | AGDAEYXRAYLXGECVEXLRXYLXLGNXTLLRXDXPKAHVTYHPRS/GPHXLRYFXTAVXWPGLVXPRFIXVGYVXDTQFV/MDFGXLPPEXNSXRMYAGXGAXPMMAAXAAWNGLAXELGTXAASY/LFXNGGAGGQGGXGGXGGXGGXGGXGMAXGPAGGTGGIGXIGGIG (the “X” represents any of 20 amino acids) Servín-Blanco et al. (2018) |
| MAG-Tn3 | QYIKANSKFIGITEL Ganneau et al. (2017) |